Article
Atlanta-A lithotripter with a broad focal spot is advantageous for accelerating stone fracture, said Robin O. Cleveland, PhD, at the AUA annual meeting here.
Application submitted to FDA for 510(k) clearance of Men’s Sexual Health Test
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Clarifying CPT 52353 billing for same-side stone cases
Pearls & Perspectives: Expanding BPH care & patient choice, with Kevin Zorn, MD, at AUA 25
Case study: 69-year-old Black man with mHSPC
FDA Advisory Committee unanimously votes against talazoparib plus enzalutamide for mCRPC
Combination therapy linked to longer OS vs ADT in veterans with mHSPC
Expert discusses the promise of emerging MISTs for BPH